Doxorubicin-Induced Cardiotoxicity: Exploration of Molecular Pathogenesis and Phytocompound-Based Therapeutic Strategies
Plant-derived bioactive compounds show potential in mitigating doxorubicin-induced cardiotoxicity, as supported by preclinical evidence. However, further translational studies are warranted to validate these findings, optimize pharmacokinetics, and evaluate their feasibility in clinical oncology settings.
Authors
- Sameer N. Goyal (ORCID: https://orcid.org/0000-0002-5241-7049)
- Harshal D. Pawar (ORCID: https://orcid.org/0009-0004-0813-8554)
- Kartik T. Nakhate (ORCID: https://orcid.org/0000-0002-7585-441X)
- Tarun Sharma (ORCID: https://orcid.org/0000-0003-4624-1427)
- Sanskruti Dusane
Institutions
- Shri Vile Parle Kelavani Mandal (IN)
Publication Details
- Journal
- Current Pharmaceutical Design
- Published
- 2025-11-03
- DOI
- https://doi.org/10.2174/0113816128410093251006160508
- Citations
- 2
- Primary Topic
- Chemotherapy-induced cardiotoxicity and mitigation
- Type
- article
- Field-Weighted Citation Impact
- 2.78